Published online Feb 16, 2022. doi: 10.12998/wjcc.v10.i5.1639
Peer-review started: August 7, 2021
First decision: November 6, 2021
Revised: November 14, 2021
Accepted: January 11, 2022
Article in press: January 11, 2022
Published online: February 16, 2022
Processing time: 187 Days and 20.8 Hours
Disseminated peritoneal leiomyomatosis (DPL) with myxoid leiomyosarcoma is a rare variant of leiomysosarcoma, and hematuria as a presenting symptom has never been reported. Through this case report, we emphasize the investigation of the etiology, clinical presentation, diagnosis, treatment, and prognosis of DPL with malignant changes mimicking metastatic urinary tract cancer and to help develop further clinical management.
We describe a case of DPL with malignant transformation involving the right ureter after laparoscopic hysterectomy. An exploratory laparotomy was performed and all visible nodules were surgically removed. DPL with focal malignant transformation to myxoid leiomyosarcoma was confirmed based on pathology results.
Professionals who preoperatively diagnose DPL with malignant change to myxoid leiomyosarcoma involving the genitourinary tract should consider symptoms of abdominal pain, hematuria, and imaging of disseminated pelvic tumors in women, especially those with prior history of laparoscopic hysterectomy. Early complete removal of all tumors is the cornerstone to prevent DPL from malignant changes.
Core Tip: Disseminated peritoneal leiomyomatosis (DPL) is a rare disease characterized by the presence of multiple nodules composed of smooth muscle cells located in both peritoneal and extraperitoneal spaces of the abdomen. Malignant changes in DPL correspond to a rare variant of leiomyosarcoma characterized by aggressive behavior. We describe a case of DPL with malignant transformation involving the right ureter after laparoscopic hysterectomy, mimicking urothelial carcinoma with peritoneal carcinomatosis. The aim of our case report is to investigate the etiology, clinical presentation, diagnosis, treatment, and prognosis of DPL and to help develop further clinical management of this disease.